Versor Investments’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,500
Closed -$737K 708
2023
Q4
$737K Buy
3,500
+879
+34% +$188K 0.15% 210
2023
Q3
$525K Sell
2,621
-5,500
-68% -$1.09M 0.11% 294
2023
Q2
$1.5M Buy
8,121
+5,821
+253% +$1.08M 0.26% 38
2023
Q1
$440K Sell
2,300
-8,931
-80% -$1.61M 0.06% 368
2022
Q4
$1.89M Sell
11,231
-8,674
-44% -$1.51M 0.16% 47
2022
Q3
$3.53M Buy
19,905
+10,036
+102% +$1.98M 0.21% 36
2022
Q2
$2.02M Buy
9,869
+8,769
+797% +$1.86M 0.08% 98
2022
Q1
$262K Buy
+1,100
New +$258K 0.01% 522
2021
Q4
Sell
-1,400
Closed -$271K 550
2021
Q3
$271K Hold
1,400
0.01% 406
2021
Q2
$298K Buy
+1,400
New +$296K 0.01% 243

Other funds holding CME

Versor Investments's CME Position: Q1 2024 in Review

Versor Investments sold out of CME Group (CME) in Q1 2024, closing a stake of 3,500 shares — an estimated $737K sold.

Versor Investments first reported a position in CME in Q2 2021 and held it in 10 quarters. The position peaked at $3.53M in Q3 2022. 1,372 funds tracked by Wall St. Rank hold CME as of Q1 2024.

  • Versor Investments reported no remaining CME Group position as of Q1 2024 after selling out during the quarter.
  • Versor Investments sold 3,500 CME Group shares in Q1 2024, an estimated $737K.
  • Versor Investments first reported a position in CME Group in Q2 2021 and held it in 10 quarters.
  • Versor Investments's CME Group position peaked at $3.53M in Q3 2022.
  • 1,372 funds tracked by Wall St. Rank held CME Group as of Q1 2024.

Based on Versor Investments's 13F filing for Q1 2024, filed 13 May 2024.